• Title of article

    Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study

  • Author/Authors

    Michael W. Rich، نويسنده , , Frances McSherry، نويسنده , , William O. Williford، نويسنده , , Salim Yusuf، نويسنده , , Salim Yusuf and Digitalis Investigation Group، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2001
  • Pages
    8
  • From page
    806
  • To page
    813
  • Abstract
    OBJECTIVES This study was designed to determine the effect of increasing age on mortality, hospitalizations and digoxin side effects in patients with heart failure (HF), and to determine whether the effect of digoxin on clinical outcomes varies as a function of age. BACKGROUND The incidence and prevalence of HF increase with advancing age, but there are limited data on the clinical course and response to specific therapeutic interventions in elderly patients with HF. METHODS The Digitalis Investigation Group (DIG) study was a prospective, randomized clinical trial involving 7,788 patients with HF randomized to digoxin or placebo and followed for an average of 37 months. In the present analysis, patients were stratified into five age categories: <50 years (n = 841), 50 to 59 years (n = 1,545), 60 to 69 years (n = 2,885), 70 to 79 years (n = 2,092) and ≥80 years (n = 425). Interactions between age and the following clinical outcomes were examined: total mortality, all-cause hospitalizations, HF hospitalizations, the composite of HF death or HF hospitalization, hospitalization for suspected digoxin toxicity and withdrawal from therapy because of side effects. RESULTS Increasing age was an independent risk factor for total mortality, all-cause hospitalization, HF hospitalization, HF death or hospital admission, hospitalization for suspected digoxin toxicity and withdrawal from digoxin therapy (all p < 0.001). However, there were no significant interactions between age and digoxin treatment with respect to any of the major clinical end points. CONCLUSIONS Increasing age is associated with progressively worse clinical outcomes in patients with HF. However, the beneficial effects of digoxin in reducing all-cause admissions, HF admissions, and HF death or hospitalization are independent of age. Thus, digoxin remains a useful agent for the adjunctive treatment of HF due to impaired left ventricular systolic function in patients of all ages.
  • Keywords
    ACE , angiotensin-converting enzyme , DIG , Digitalis Investigation Group , heart failure , LVEF , Hf , left ventricular ejection fraction
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2001
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    596787